Pathway Name Avg Num Perturbations Total Perturbations Num Entities Min Mean Truth Max Mean Truth Min Mean Within Max Mean Within Min Mean Any Max Mean Within FOXA2 and FOXA3 transcription factor networks 15.0 709.0 46.0 -0.98 0.029 1000.0 -1000.0 -0.135 -1000.0 Nephrin/Neph1 signaling in the kidney podocyte 9.0 315.0 34.0 -0.369 0.013 1000.0 -1000.0 -0.103 -1000.0 IL23-mediated signaling events 9.0 555.0 60.0 -0.681 0.013 1000.0 -1000.0 -0.22 -1000.0 IL4-mediated signaling events 8.0 797.0 91.0 -0.835 0.776 1000.0 -1000.0 -0.208 -1000.0 HIF-1-alpha transcription factor network 7.0 598.0 76.0 -0.71 0.022 1000.0 -1000.0 -0.26 -1000.0 TCGA08_retinoblastoma 7.0 56.0 8.0 -0.211 0.07 1000.0 -1000.0 -0.034 -1000.0 Signaling events mediated by the Hedgehog family 6.0 337.0 52.0 -0.215 0.161 1000.0 -1000.0 -0.118 -1000.0 p75(NTR)-mediated signaling 6.0 768.0 125.0 -0.397 0.013 1000.0 -1000.0 -0.164 -1000.0 IL6-mediated signaling events 6.0 478.0 75.0 -0.613 0.047 1000.0 -1000.0 -0.143 -1000.0 BCR signaling pathway 6.0 661.0 99.0 -0.501 0.014 1000.0 -1000.0 -0.145 -1000.0 Ephrin A reverse signaling 5.0 35.0 7.0 -0.067 0.0 1000.0 -1000.0 -0.041 -1000.0 Signaling events mediated by PTP1B 5.0 381.0 76.0 -0.476 0.09 1000.0 -1000.0 -0.126 -1000.0 Glypican 1 network 5.0 255.0 48.0 -0.484 0.037 1000.0 -1000.0 -0.069 -1000.0 amb2 Integrin signaling 5.0 426.0 82.0 -0.335 0.013 1000.0 -1000.0 -0.14 -1000.0 TCR signaling in naïve CD8+ T cells 5.0 472.0 93.0 -0.226 0.108 1000.0 -1000.0 -0.136 -1000.0 Wnt signaling 5.0 36.0 7.0 -0.245 0.013 1000.0 -1000.0 -0.053 -1000.0 EGFR-dependent Endothelin signaling events 5.0 118.0 21.0 -0.429 0.013 1000.0 -1000.0 -0.123 -1000.0 Visual signal transduction: Rods 5.0 287.0 52.0 -0.407 0.013 1000.0 -1000.0 -0.139 -1000.0 IL12-mediated signaling events 4.0 394.0 87.0 -0.35 0.057 1000.0 -1000.0 -0.184 -1000.0 Visual signal transduction: Cones 4.0 157.0 38.0 -0.207 0.013 1000.0 -1000.0 -0.109 -1000.0 Glucocorticoid receptor regulatory network 4.0 569.0 114.0 -0.695 0.327 1000.0 -1000.0 -0.122 -1000.0 Reelin signaling pathway 4.0 270.0 56.0 -0.296 0.013 1000.0 -1000.0 -0.142 -1000.0 TCGA08_p53 4.0 30.0 7.0 -0.162 0.07 1000.0 -1000.0 -0.02 -1000.0 Signaling mediated by p38-alpha and p38-beta 4.0 193.0 44.0 -0.237 0.013 1000.0 -1000.0 -0.08 -1000.0 Effects of Botulinum toxin 4.0 112.0 26.0 -0.231 0.019 1000.0 -1000.0 -0.099 -1000.0 Calcium signaling in the CD4+ TCR pathway 4.0 129.0 31.0 -0.394 0.014 1000.0 -1000.0 -0.136 -1000.0 Calcineurin-regulated NFAT-dependent transcription in lymphocytes 4.0 318.0 68.0 -0.476 0.13 1000.0 -1000.0 -0.195 -1000.0 IGF1 pathway 4.0 237.0 57.0 -0.291 0.066 1000.0 -1000.0 -0.152 -1000.0 Insulin Pathway 4.0 305.0 74.0 -0.471 0.029 1000.0 -1000.0 -0.153 -1000.0 Class IB PI3K non-lipid kinase events 4.0 12.0 3.0 -0.047 -1000.0 1000.0 -1000.0 -0.027 -1000.0 Syndecan-1-mediated signaling events 3.0 103.0 34.0 -0.27 0.013 1000.0 -1000.0 -0.113 -1000.0 Lissencephaly gene (LIS1) in neuronal migration and development 3.0 162.0 54.0 -0.286 0.025 1000.0 -1000.0 -0.162 -1000.0 JNK signaling in the CD4+ TCR pathway 3.0 67.0 17.0 -0.154 0.013 1000.0 -1000.0 -0.1 -1000.0 Arf6 signaling events 3.0 209.0 62.0 -0.429 0.014 1000.0 -1000.0 -0.104 -1000.0 RXR and RAR heterodimerization with other nuclear receptor 3.0 180.0 52.0 -0.365 0.055 1000.0 -1000.0 -0.103 -1000.0 Glypican 2 network 3.0 12.0 4.0 -0.045 -0.044 1000.0 -1000.0 -0.058 -1000.0 Syndecan-4-mediated signaling events 3.0 246.0 67.0 -0.284 0.053 1000.0 -1000.0 -0.142 -1000.0 Plasma membrane estrogen receptor signaling 3.0 286.0 86.0 -0.292 0.066 1000.0 -1000.0 -0.135 -1000.0 Neurotrophic factor-mediated Trk receptor signaling 3.0 446.0 120.0 -0.46 0.212 1000.0 -1000.0 -0.146 -1000.0 ErbB4 signaling events 2.0 180.0 69.0 -0.318 0.165 1000.0 -1000.0 -0.14 -1000.0 Noncanonical Wnt signaling pathway 2.0 73.0 26.0 -0.245 0.013 1000.0 -1000.0 -0.129 -1000.0 Thromboxane A2 receptor signaling 2.0 272.0 105.0 -0.429 0.032 1000.0 -1000.0 -0.124 -1000.0 Syndecan-2-mediated signaling events 2.0 143.0 69.0 -0.208 0.045 1000.0 -1000.0 -0.102 -1000.0 a4b1 and a4b7 Integrin signaling 2.0 10.0 5.0 -0.047 -0.003 1000.0 -1000.0 -0.06 -1000.0 BMP receptor signaling 2.0 217.0 81.0 -0.328 0.058 1000.0 -1000.0 -0.147 -1000.0 Fc-epsilon receptor I signaling in mast cells 2.0 286.0 97.0 -0.207 0.035 1000.0 -1000.0 -0.142 -1000.0 mTOR signaling pathway 2.0 134.0 53.0 -0.476 0.033 1000.0 -1000.0 -0.099 -1000.0 Paxillin-independent events mediated by a4b1 and a4b7 2.0 96.0 37.0 -0.208 0.013 1000.0 -1000.0 -0.137 -1000.0 Signaling events regulated by Ret tyrosine kinase 2.0 232.0 82.0 -0.215 0.013 1000.0 -1000.0 -0.146 -1000.0 HIF-2-alpha transcription factor network 2.0 108.0 43.0 -0.117 0.031 1000.0 -1000.0 -0.134 -1000.0 Endothelins 2.0 265.0 96.0 -0.267 0.075 1000.0 -1000.0 -0.131 -1000.0 S1P1 pathway 2.0 73.0 36.0 -0.187 0.013 1000.0 -1000.0 -0.094 -1000.0 FAS signaling pathway (CD95) 2.0 115.0 47.0 -0.346 0.056 1000.0 -1000.0 -0.086 -1000.0 Syndecan-3-mediated signaling events 2.0 87.0 35.0 -0.151 0.013 1000.0 -1000.0 -0.107 -1000.0 Integrins in angiogenesis 2.0 202.0 84.0 -0.292 0.027 1000.0 -1000.0 -0.149 -1000.0 Nongenotropic Androgen signaling 2.0 113.0 52.0 -0.094 0.013 1000.0 -1000.0 -0.104 -1000.0 IL27-mediated signaling events 2.0 151.0 51.0 -0.332 0.04 1000.0 -1000.0 -0.151 -1000.0 LPA receptor mediated events 2.0 276.0 102.0 -0.208 0.035 1000.0 -1000.0 -0.144 -1000.0 Angiopoietin receptor Tie2-mediated signaling 2.0 238.0 88.0 -0.157 0.053 1000.0 -1000.0 -0.151 -1000.0 Rapid glucocorticoid signaling 2.0 44.0 20.0 -0.265 0.013 1000.0 -1000.0 -0.071 -1000.0 Signaling events mediated by Stem cell factor receptor (c-Kit) 2.0 157.0 78.0 -0.202 0.058 1000.0 -1000.0 -0.116 -1000.0 Ras signaling in the CD4+ TCR pathway 2.0 39.0 17.0 -0.097 0.014 1000.0 -1000.0 -0.071 -1000.0 LPA4-mediated signaling events 1.0 13.0 12.0 -0.023 0.022 1000.0 -1000.0 -0.044 -1000.0 Caspase cascade in apoptosis 1.0 98.0 74.0 -0.109 0.025 1000.0 -1000.0 -0.089 -1000.0 Regulation of nuclear SMAD2/3 signaling 1.0 174.0 136.0 -0.202 0.09 1000.0 -1000.0 -0.127 -1000.0 Coregulation of Androgen receptor activity 1.0 134.0 76.0 -0.205 0.033 1000.0 -1000.0 -0.075 -1000.0 Sphingosine 1-phosphate (S1P) pathway 1.0 34.0 28.0 -0.094 0.026 1000.0 -1000.0 -0.093 -1000.0 Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met) 1.0 100.0 85.0 -0.093 0.027 1000.0 -1000.0 -0.118 -1000.0 Presenilin action in Notch and Wnt signaling 1.0 112.0 61.0 -0.323 0.04 1000.0 -1000.0 -0.118 -1000.0 EPO signaling pathway 1.0 77.0 55.0 -0.2 0.015 1000.0 -1000.0 -0.165 -1000.0 Ceramide signaling pathway 1.0 134.0 76.0 -0.429 0.12 1000.0 -1000.0 -0.108 -1000.0 IL1-mediated signaling events 1.0 75.0 62.0 -0.143 0.066 1000.0 -1000.0 -0.156 -1000.0 S1P5 pathway 1.0 28.0 17.0 -0.094 0.061 1000.0 -1000.0 -0.094 -1000.0 Ephrin B reverse signaling 1.0 52.0 48.0 -0.108 0.03 1000.0 -1000.0 -0.122 -1000.0 Retinoic acid receptors-mediated signaling 1.0 95.0 58.0 -0.266 0.023 1000.0 -1000.0 -0.123 -1000.0 Canonical Wnt signaling pathway 1.0 101.0 51.0 -0.323 0.083 1000.0 -1000.0 -0.092 -1000.0 Regulation of p38-alpha and p38-beta 1.0 70.0 54.0 -0.427 0.013 1000.0 -1000.0 -0.099 -1000.0 Stabilization and expansion of the E-cadherin adherens junction 1.0 75.0 74.0 -0.429 0.081 1000.0 -1000.0 -0.148 -1000.0 Class I PI3K signaling events 1.0 76.0 73.0 -0.427 0.04 1000.0 -1000.0 -0.122 -1000.0 Regulation of Telomerase 1.0 173.0 102.0 -0.43 0.053 1000.0 -1000.0 -0.153 -1000.0 Hypoxic and oxygen homeostasis regulation of HIF-1-alpha 1.0 49.0 33.0 -0.209 0.036 1000.0 -1000.0 -0.108 -1000.0 FOXM1 transcription factor network 1.0 65.0 51.0 -0.22 0.149 1000.0 -1000.0 -0.232 -1000.0 S1P4 pathway 1.0 45.0 25.0 -0.094 0.013 1000.0 -1000.0 -0.09 -1000.0 p38 MAPK signaling pathway 1.0 69.0 44.0 -0.279 0.019 1000.0 -1000.0 -0.106 -1000.0 Regulation of Androgen receptor activity 1.0 133.0 70.0 -0.345 0.076 1000.0 -1000.0 -0.103 -1000.0 ErbB2/ErbB3 signaling events 0.0 59.0 65.0 -0.16 0.031 1000.0 -1000.0 -0.117 -1000.0 Regulation of cytoplasmic and nuclear SMAD2/3 signaling 0.0 0.0 23.0 0.0 0.052 1000.0 -1000.0 -0.119 -1000.0 Canonical NF-kappaB pathway 0.0 13.0 39.0 -0.074 0.092 1000.0 -1000.0 -0.14 -1000.0 Signaling events mediated by HDAC Class II 0.0 42.0 75.0 -0.096 0.039 1000.0 -1000.0 -0.104 -1000.0 BARD1 signaling events 0.0 36.0 57.0 -0.025 0.067 1000.0 -1000.0 -0.106 -1000.0 PLK2 and PLK4 events 0.0 2.0 3.0 -0.001 0.014 1000.0 -1000.0 -0.034 -1000.0 Circadian rhythm pathway 0.0 15.0 22.0 -0.016 0.035 1000.0 -1000.0 -0.094 -1000.0 Osteopontin-mediated events 0.0 25.0 38.0 -0.077 0.016 1000.0 -1000.0 -0.172 -1000.0 Cellular roles of Anthrax toxin 0.0 32.0 39.0 -0.074 0.021 1000.0 -1000.0 -0.062 -1000.0 Hedgehog signaling events mediated by Gli proteins 0.0 26.0 65.0 -0.093 0.082 1000.0 -1000.0 -0.104 -1000.0 Aurora A signaling 0.0 21.0 60.0 -0.078 0.033 1000.0 -1000.0 -0.1 -1000.0 Arf6 downstream pathway 0.0 16.0 43.0 -0.015 0.027 1000.0 -1000.0 -0.067 -1000.0 Aurora C signaling 0.0 0.0 7.0 0.0 0.013 1000.0 -1000.0 -0.069 -1000.0 PLK1 signaling events 0.0 13.0 85.0 -0.012 0.037 1000.0 -1000.0 -0.089 -1000.0 Insulin-mediated glucose transport 0.0 9.0 32.0 -0.035 0.043 1000.0 -1000.0 -0.099 -1000.0 PDGFR-alpha signaling pathway 0.0 12.0 44.0 -0.055 0.034 1000.0 -1000.0 -0.095 -1000.0 IFN-gamma pathway 0.0 61.0 68.0 -0.279 0.039 1000.0 -1000.0 -0.156 -1000.0 Class I PI3K signaling events mediated by Akt 0.0 17.0 68.0 -0.044 0.06 1000.0 -1000.0 -0.097 -1000.0 Nectin adhesion pathway 0.0 13.0 63.0 -0.029 0.067 1000.0 -1000.0 -0.114 -1000.0 Signaling events mediated by HDAC Class III 0.0 28.0 40.0 -0.083 0.025 1000.0 -1000.0 -0.064 -1000.0 TRAIL signaling pathway 0.0 18.0 48.0 -0.032 0.06 1000.0 -1000.0 -0.112 -1000.0 ceramide signaling pathway 0.0 16.0 49.0 -0.073 0.042 1000.0 -1000.0 -0.084 -1000.0 Role of Calcineurin-dependent NFAT signaling in lymphocytes 0.0 60.0 83.0 -0.211 0.066 1000.0 -1000.0 -0.123 -1000.0 Signaling events mediated by HDAC Class I 0.0 61.0 104.0 -0.15 0.053 1000.0 -1000.0 -0.107 -1000.0 FoxO family signaling 0.0 51.0 64.0 -0.34 0.128 1000.0 -1000.0 -0.119 -1000.0 Signaling mediated by p38-gamma and p38-delta 0.0 10.0 15.0 -0.001 0.024 1000.0 -1000.0 -0.056 -1000.0 Paxillin-dependent events mediated by a4b1 0.0 24.0 36.0 -0.047 0.027 1000.0 -1000.0 -0.116 -1000.0 Atypical NF-kappaB pathway 0.0 13.0 31.0 -0.035 0.049 1000.0 -1000.0 -0.117 -1000.0 IL2 signaling events mediated by PI3K 0.0 42.0 58.0 -0.093 0.055 1000.0 -1000.0 -0.134 -1000.0 HIV-1 Nef: Negative effector of Fas and TNF-alpha 0.0 38.0 45.0 -0.169 0.052 1000.0 -1000.0 -0.143 -1000.0 EPHB forward signaling 0.0 71.0 85.0 -0.14 0.05 1000.0 -1000.0 -0.151 -1000.0 Signaling events mediated by VEGFR1 and VEGFR2 0.0 13.0 125.0 -0.026 0.096 1000.0 -1000.0 -0.167 -1000.0 TCGA08_rtk_signaling 0.0 7.0 26.0 -0.031 0.053 1000.0 -1000.0 -0.033 -1000.0 E-cadherin signaling in the nascent adherens junction 0.0 12.0 76.0 -0.018 0.067 1000.0 -1000.0 -0.13 -1000.0 Sumoylation by RanBP2 regulates transcriptional repression 0.0 2.0 27.0 -0.008 0.032 1000.0 -1000.0 -0.093 -1000.0 IL2 signaling events mediated by STAT5 0.0 14.0 22.0 -0.086 0.047 1000.0 -1000.0 -0.093 -1000.0 Arf6 trafficking events 0.0 59.0 71.0 -0.244 0.048 1000.0 -1000.0 -0.129 -1000.0 VEGFR1 specific signals 0.0 5.0 56.0 -0.017 0.074 1000.0 -1000.0 -0.126 -1000.0 S1P3 pathway 0.0 36.0 42.0 -0.092 0.028 1000.0 -1000.0 -0.098 -1000.0 PDGFR-beta signaling pathway 0.0 39.0 97.0 -0.246 0.057 1000.0 -1000.0 -0.144 -1000.0 Signaling events mediated by PRL 0.0 24.0 34.0 -0.074 0.025 1000.0 -1000.0 -0.084 -1000.0 E-cadherin signaling in keratinocytes 0.0 21.0 43.0 -0.022 0.047 1000.0 -1000.0 -0.112 -1000.0 E-cadherin signaling events 0.0 0.0 5.0 0.0 0.013 1000.0 -1000.0 -0.069 -1000.0 Arf1 pathway 0.0 5.0 54.0 -0.029 0.024 1000.0 -1000.0 -0.07 -1000.0 Alternative NF-kappaB pathway 0.0 4.0 13.0 -0.011 0.013 1000.0 -1000.0 -0.11 -1000.0 Aurora B signaling 0.0 25.0 67.0 -0.146 0.04 1000.0 -1000.0 -0.108 -1000.0 Total 263 18324 7203 -29.0758969393 -993.299412898 131000 -131000 -15.0881101117 -131000